Current landscape and challenges of neuro-oncological molecular tumor boards in Germany: results of a nationwide follow-up survey - Quiz - MDSpire

Current landscape and challenges of neuro-oncological molecular tumor boards in Germany: results of a nationwide follow-up survey

  • By

  • Lisa S. Hönikl

  • Sebastian Lange

  • Bernhard Meyer

  • Stephanie E. Combs

  • Alisa M. Lörsch

  • Anna Lena Illert

  • Arthur Wagner

  • Friederike Schmidt-Graf

  • March 31, 2026

  • 0 min

Share

Original Source(s)

Current landscape and challenges of neuro-oncological molecular tumor boards in Germany: results of a nationwide follow-up survey

  • by Lisa S. Hönikl, Sebastian Lange, Bernhard Meyer, Stephanie E. Combs, Alisa M. Lörsch, Anna Lena Illert, Arthur Wagner, Friederike Schmidt-Graf

  • March 31, 2026

Related Content

Management of toxicities from antibody – drug conjugates in breast cancer

Retraction: MicroRNA-935 directly targets FZD6 to inhibit the proliferation of human glioblastoma and correlate to glioma malignancy and prognosis

  • May 28, 2026

Case Report: [225Ac]Ac-PSMA-617 therapy in a patient with metastatic castration-resistant prostate cancer (mCRPC) and intracranial meningioma